Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Delisting Woes Continue To Hit China Pharma Companies

This article was originally published in PharmAsia News

Executive Summary

American Stock Exchange-listed Shenghuo Pharmaceutical Holdings is facing potential delisting proceedings because of its inability to provide Q2 2008 financial reports on schedule. Initial statements showed accounting errors in representative commission advances and trade receivables, which implicated the company's employees and internal controls. Shenghuo and its directors have been sued by an American law firm for the violation of the U.S. Securities Exchange Act. In response, the company has set up an internal audit committee to examine its finances and has declined comment until results are released Nov. 19. Analysts observe that in the rush to go public, many firms in China have encountered delisting woes due to their lack of solid grounding and preparation for such an undertaking. (Click here for more - Chinese Language)
Advertisement
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC066854

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel